Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Roberto D'Alessio
Introduction
Roberto D'Alessio, an accomplished inventor based in Cinisello Balsamo, Italy, has made significant strides in the field of immunosuppressive therapies. With a patented invention to his name, he has contributed to advancements that hold promise for improving patient care in this essential area of medicine.
Latest Patents
D'Alessio's most notable patent is for a synergistic immunosuppressant composition that contains a 2,2'-bi-1H-pyrrole compound. This innovative product includes an immunosuppressant agent (A) alongside at least one 2,2'-bi-1H-pyrrole compound (B). The patent describes various formulations where the components possess multiple substituents, providing a unique approach to enhance immunosuppressive activity. This composition is designed for simultaneous, separate, or sequential use in immunosuppressant therapy, demonstrating a potent immunosuppressive effect compared to products containing either component alone.
Career Highlights
Roberto D'Alessio is affiliated with Pharmacia & Upjohn S.p.a., a company well-regarded for its contributions to pharmaceuticals. His work is characterized by a dedication to advancing immunotherapy, aiming to enhance therapeutic outcomes for patients requiring immunosuppression.
Collaborations
Throughout his career, D'Alessio has collaborated with esteemed colleagues, including Mario Ferrari and Paola Gnocchi. These partnerships have fostered a creative environment conducive to innovation, driving the development of promising therapeutic compositions.
Conclusion
Roberto D'Alessio exemplifies the spirit of invention in the pharmaceutical industry. With his patent on synergistic immunosuppressant compositions, he stands at the forefront of innovation, contributing to advancements that may revolutionize immunosuppressive therapies for patients worldwide.